Trademark applications and grants for Penwest Pharmaceuticals Co. Penwest Pharmaceuticals Co has 17 trademark applications. The latest application filed is for "GEMINEX"
Patent Application | Date |
---|---|
SUSTAINED RELEASE FORMULATION OF NALBUPHINE 20140271852 - 14/290413 BAICHWAL; Anand R. ;   et al. | 2014-09-18 |
SUSTAINED RELEASE MATRIX SYSTEMS FOR HIGHLY SOLUBLE DRUGS 20140242166 - 14/195127 Baichwal; Anand R. ;   et al. | 2014-08-28 |
SUSTAINED RELEASE FORMULATION OF NALBUPHINE 20130164350 - 13/773136 BAICHWAL; ANAND R. ;   et al. | 2013-06-27 |
METHODS OF PROVIDING ANTICOAGULATION EFFECTS IN SUBJECTS 20120101169 - 13/180185 HAWI; Amale | 2012-04-26 |
SYNTHESIS OF ALPHA-TOCOPHEROLQUINONE DERIVATIVES, AND METHODS OF USING THE SAME 20110263720 - 13/044056 PAISLEY; Steven D. ;   et al. | 2011-10-27 |
NCAGE Code | 594H3 | PENWEST PHARMACEUTICALS CO. |
CAGE Code | 594H3 | PENWEST PHARMACEUTICALS CO. |
DUNS | 002536456 | PENWEST PHARMACEUTICALS CO. |
SEC | 0001047188 | PENWEST PHARMACEUTICALS CO of WASHINGTON |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.